Responding to press reports, Merck KGaA (MKGAY.PK) confirmed late-stage discussions with SpringWorks Therapeutics Inc. (SWTX) on a potential acquisition.
Merck KGaA noted that the companies are in discussion on the basis of a price of around US$47 per share. No final decision has been taken and no legally binding agreement has been entered into.
SWTX closed Thursday's regular trading at $44.93 up $3.72 or 9.03%. But in the after-hours trading, the stock dipped by $0.08 or 0.18%.
For comments and feedback contact: editorial@rttnews.com
Business News
April 24, 2026 15:15 ET Economics news flow was relatively light this week even as the conflict in the Middle East continued, raising concerns for policymakers. In the U.S., spending data, initial jobless claims and pending home sales were the highlights. Business confidence in the biggest euro area economy was in focus in Europe. Inflation data from Japan gained attention in Asia.